Back

Prevalence and prognostic implication of iron deficiency in patients with severe aortic stenosis

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Valvular Heart Disease – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Kaspar Broch

Oslo University Hospital Rikshospitalet, Oslo (Norway)

5 More presentations in this session

Presentation thumbnail
Doctor S. Aschauer (Vienna, AT)
Abstract
Presentation thumbnail
Doctor E. Munoz Garcia (Malaga, ES)
Abstract Slides
Presentation thumbnail
Doctor R. Carvalheira dos Santos (Setubal, PT)
Abstract
Presentation thumbnail
Doctor A. Gomes (Almada, PT)
Abstract
Presentation thumbnail
Doctor A. Gomes (Almada, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Valvular Heart Disease – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The IIISAS trial: a randomized controlled trial designed to assess the effect of ferric derisomaltose on physical capacity in patients with aortic stenosis and iron deficiency undergoing TAVI
29 June 2021
thumbnail
Webinar
Aortic stenosis treatment options - which therapy for which patient?
21 December 2021
thumbnail
Congress Presentation
Conclusion
26 August 2023
thumbnail
Congress Presentation
Prevalence of sideropenia and sideropenic anemia in patients hospitalized for heart failure
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources